secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPT Therapeutics, Inc. (—)
CIK:        0001673772
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0000950170-25-087359
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RAPT Therapeutics effects 1-for-8 reverse stock split; post-split shares ~16.5M
-------------------------------------------------------------------------------

- Stockholders approved reverse split at May 29, 2025 annual meeting.
- Effective June 16, 2025, RAPT effected a 1-for-8 reverse stock split.
- Post-split shares outstanding approx. 16.5 million (before eliminating fractional shares).
- Certificate of Amendment filed with Delaware on June 13, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1673772/000095017025087359/0000950170-25-087359-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1673772/000095017025087359/rapt-20250613.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-087359

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer